Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1569, 2007-01, pp. : 1-1
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Benefits of antineoplastics outweigh risks in elderly NSCLC
Reactions Weekly, Vol. 1, Iss. 1361, 2011-01 ,pp. :
Access to resources
Recommend
Bank on bevacizumab to save money in NSCLC
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 580, 2009-01 ,pp. :
Bevacizumab combination improves survival in advanced NSCLC
Inpharma, Vol. 1, Iss. 1492, 2005-01 ,pp. :
Risks and benefits of perioperative -blockers
Reactions Weekly, Vol. 1, Iss. 1203, 2008-01 ,pp. :
Risks and benefits of allergen immunotherapy
By Rogala Barbara Glück Joanna
Expert Opinion on Drug Safety, Vol. 8, Iss. 3, 2009-05 ,pp. :